Related Experiment Video
Updated: May 23, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells
Miao Sun1, Gary D Isaacs, Nasun Hah
1Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8511, USA.
Abstract:
Steroid hormone and MAPK signaling pathways functionally intersect, but the molecular mechanisms of this cross talk are unclear. Here, we demonstrate a functional convergence of the estrogen and c-Jun N-terminal kinase 1 (JNK1) signaling pathways at the genomic level in breast cancer cells. We find that JNK1 binds to many promoters across the genome. Although most of the JNK1-binding sites are constitutive, a subset is estrogen regulated (either induced on inhibited). At the estrogen-induced sites, estrogen receptor (ER)α is required for the binding of JNK1 by promoting its recruitment to estrogen response elements or other classes of DNA elements through a tethering mechanism, which in some cases involves activating protein-1. At estrogen-regulated promoters, JNK1 functions as a transcriptional coregulator of ERα in a manner that is dependent on its kinase activity. The convergence of ERα and JNK1 at target gene promoters regulates estrogen-dependent gene expression outcomes, as well as downstream estrogen-dependent cell growth responses. Analysis of existing gene expression profiles from breast cancer biopsies suggests a role for functional interplay between ERα and JNK1 in the progression and clinical outcome of breast cancers.
Insights
Estrogen and c-Jun N-terminal kinase 1 (JNK1) signaling pathways converge at the genome in breast cancer cells. This interaction, regulated by estrogen receptor alpha (ERα), influences gene expression and cell growth, impacting cancer progression.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Biology
Background:
- Steroid hormone and MAPK signaling pathways are known to intersect.
- The precise molecular mechanisms underlying this cross-talk, particularly between estrogen and JNK1, remain largely undefined.
Purpose of the Study:
- To elucidate the genomic convergence of estrogen receptor alpha (ERα) and c-Jun N-terminal kinase 1 (JNK1) signaling pathways in breast cancer cells.
- To investigate the functional consequences of this ERα-JNK1 interplay on gene expression and cell proliferation.
Main Methods:
- Genome-wide analysis of JNK1 binding sites in breast cancer cells.
- Chromatin immunoprecipitation (ChIP) assays to determine ERα and JNK1 occupancy at target promoters.
- Kinase activity assays for JNK1.
- Analysis of gene expression profiles and breast cancer patient data.
Main Results:
- JNK1 binds to numerous genomic promoters, with a subset being estrogen-regulated.
- ERα is essential for JNK1 recruitment to specific DNA elements, often involving activating protein-1.
- JNK1 acts as a kinase-dependent transcriptional coregulator of ERα at target promoters.
- This convergence regulates estrogen-dependent gene expression and cell growth.
Conclusions:
- Estrogen and JNK1 signaling pathways functionally converge at the genomic level in breast cancer.
- The interplay between ERα and JNK1 influences estrogen-driven gene expression and cell proliferation.
- This ERα-JNK1 functional interplay may play a significant role in breast cancer progression and clinical outcomes.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

